落实中医药法:《天津市中医药条例》立法调研工作启动

2018-03-20 朱蕗鋆 中国中医

为贯彻落实《中华人民共和国中医药法》,加强地方中医药法制建设,建立健全中医药法规及相关制度,天津市卫生计生委将《天津市中医药条例》立法调研及起草列为2018年度重点工作。为高质量完成《天津市中医药条例(草案)》起草,确保立法反映党和政府对中医药事业发展要求,回应人民群众关切和期待,天津市卫生计生委于3月份启动了立法调研工作。3月14日至15日,天津市卫生计生委调研工作组由市卫生计生委巡视员、副主任

为贯彻落实《中华人民共和国中医药法》,加强地方中医药法制建设,建立健全中医药法规及相关制度,天津市卫生计生委将《天津市中医药条例》立法调研及起草列为2018年度重点工作。为高质量完成《天津市中医药条例(草案)》起草,确保立法反映党和政府对中医药事业发展要求,回应人民群众关切和期待,天津市卫生计生委于3月份启动了立法调研工作。3月14日至15日,天津市卫生计生委调研工作组由市卫生计生委巡视员、副主任申长虹同志带队先后赴江苏省、山东省开展立法调研工作。

调研组一行同两省中医药管理部门、当地中医医疗机构负责同志、中医药专家举行了座谈,就立法工作流程、遇到的困难和问题、如何在立法工作中体现和保护地方中医药传承发展特色和优势等问题深入交换了意见,就贯彻落实中医药法中的热点问题,如确有专长人员考核管理工作、中医诊所备案流程及监督工作等进行了讨论。同时,调研组实地调研了江苏省中医院和山东中医药大学附属医院,听取了当地中医药专家、中医医疗机构相关负责同志对贯彻落实中医药法、完善中医药地方性法规的意见建议。

调研组组长申长虹同志表示,今年天津市卫生计生委将持续开展本市及外阜的立法调研工作,充分学习各省市在中医药地方条例制修订中的经验,全面了解我市中医药立法需求,广泛征求社会各界对中医药地方条例的意见建议,力争《天津市中医药条例(草案)》能切实保障新时代中医药的传承发展、推动和保障健康天津、健康中国战略的实施。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1656319, encodeId=dbd416563195b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Dec 17 16:40:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751444, encodeId=32931e5144483, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Sat Dec 08 22:40:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803679, encodeId=0c1f18036e904, content=<a href='/topic/show?id=b950e5627dc' target=_blank style='color:#2F92EE;'>#立法调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75627, encryptionId=b950e5627dc, topicName=立法调研)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Thu Nov 01 12:40:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409433, encodeId=a3f21409433f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 22 10:40:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298243, encodeId=b80a29824342, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 21 07:16:10 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298234, encodeId=19a729823437, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Wed Mar 21 07:10:51 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1656319, encodeId=dbd416563195b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Dec 17 16:40:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751444, encodeId=32931e5144483, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Sat Dec 08 22:40:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803679, encodeId=0c1f18036e904, content=<a href='/topic/show?id=b950e5627dc' target=_blank style='color:#2F92EE;'>#立法调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75627, encryptionId=b950e5627dc, topicName=立法调研)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Thu Nov 01 12:40:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409433, encodeId=a3f21409433f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 22 10:40:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298243, encodeId=b80a29824342, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 21 07:16:10 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298234, encodeId=19a729823437, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Wed Mar 21 07:10:51 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1656319, encodeId=dbd416563195b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Dec 17 16:40:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751444, encodeId=32931e5144483, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Sat Dec 08 22:40:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803679, encodeId=0c1f18036e904, content=<a href='/topic/show?id=b950e5627dc' target=_blank style='color:#2F92EE;'>#立法调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75627, encryptionId=b950e5627dc, topicName=立法调研)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Thu Nov 01 12:40:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409433, encodeId=a3f21409433f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 22 10:40:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298243, encodeId=b80a29824342, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 21 07:16:10 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298234, encodeId=19a729823437, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Wed Mar 21 07:10:51 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1656319, encodeId=dbd416563195b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Dec 17 16:40:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751444, encodeId=32931e5144483, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Sat Dec 08 22:40:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803679, encodeId=0c1f18036e904, content=<a href='/topic/show?id=b950e5627dc' target=_blank style='color:#2F92EE;'>#立法调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75627, encryptionId=b950e5627dc, topicName=立法调研)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Thu Nov 01 12:40:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409433, encodeId=a3f21409433f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 22 10:40:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298243, encodeId=b80a29824342, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 21 07:16:10 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298234, encodeId=19a729823437, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Wed Mar 21 07:10:51 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
    2018-03-22 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1656319, encodeId=dbd416563195b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Dec 17 16:40:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751444, encodeId=32931e5144483, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Sat Dec 08 22:40:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803679, encodeId=0c1f18036e904, content=<a href='/topic/show?id=b950e5627dc' target=_blank style='color:#2F92EE;'>#立法调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75627, encryptionId=b950e5627dc, topicName=立法调研)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Thu Nov 01 12:40:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409433, encodeId=a3f21409433f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 22 10:40:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298243, encodeId=b80a29824342, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 21 07:16:10 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298234, encodeId=19a729823437, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Wed Mar 21 07:10:51 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
    2018-03-21 wzb521zf

    一起学习学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1656319, encodeId=dbd416563195b, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Dec 17 16:40:00 CST 2018, time=2018-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751444, encodeId=32931e5144483, content=<a href='/topic/show?id=3ba692039f7' target=_blank style='color:#2F92EE;'>#调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92039, encryptionId=3ba692039f7, topicName=调研)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958d36313994, createdName=天堂的云, createdTime=Sat Dec 08 22:40:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803679, encodeId=0c1f18036e904, content=<a href='/topic/show?id=b950e5627dc' target=_blank style='color:#2F92EE;'>#立法调研#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75627, encryptionId=b950e5627dc, topicName=立法调研)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Thu Nov 01 12:40:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409433, encodeId=a3f21409433f3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 22 10:40:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298243, encodeId=b80a29824342, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Mar 21 07:16:10 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298234, encodeId=19a729823437, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcVAydhtcpjiaxLrZD7Eb5YnKPgf7ypGpfyl7FflFyAenvQLbib6T0LPXIhXo9SPNPXYYFFJbEgykztwJ0HQ61I3F9GxIVKWsgQ/0, createdBy=f38d2052407, createdName=周周人, createdTime=Wed Mar 21 07:10:51 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
    2018-03-21 周周人

    学习.

    0